News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA
Photo collage of Jonathan Riess and David Gandara
Aug 27, 2024, 21:52

David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA

David Gandara, Co-Director-Center for Experimental Therapeutics at UC Davis Comprehensive Cancer Center, shared a post on X:

“At Cal Cancer Consortium conference, Jonathan Riess shows impact of baseline positive vs negative plasma ctDNA for EGFR in the FLAURA2 trial. Addition of chemo to Osi mainly benefitting those with positive ctDNA. Food for thought!”

David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA

Source: David Gandara/X

Cal Cancer Consortium cancer Cancer research chemotherapy ctDNA Impact David Gandara EGFR Experimental Therapeutics FLAURA2 Trial Jonathan Riess OncoDaily Oncology Oncology Conference osimertinib plasma ctDNA UC Davis Comprehensive Cancer Center
Special Coverage
Dialogues
Feb 22, 2025, 05:05
ASCO24 Updates: Dr. Tycel Phillips on Glofitamab in Mantle Cell Lymphoma
Blog
Feb 22, 2025, 04:54
Rick Dean is stepping down as the CEO of OncoHealth
Blog
Feb 22, 2025, 04:49
Wafaa Rashed: Advancing Ethical and Evidence-Based Policy in Genomics
Blog
Feb 22, 2025, 04:42
Jessica Schubel: I'm launching my very own health care and aging policy consulting firm - Day One Strategies
Blog
Feb 22, 2025, 04:37
Karen Knudsen: Honored to be part of the Moffitt Cancer Center External Advisory Committee
Blog
Feb 22, 2025, 04:33
SPCC announced the upcoming launch of the "Digital Oncology" book series
Blog
Feb 22, 2025, 04:29
Results from the SIOPE OCEAN project are out
Blog
Feb 22, 2025, 04:25
Empower families to face their cancer journey with strength and hope - Cancer Hope Network
Blog
Feb 22, 2025, 04:19
Secure your spot for the CCI4EU Online Course by ESO
Blog
Feb 22, 2025, 04:16
Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED
Blog
Feb 22, 2025, 04:12
Citrus Oncology is part of the 14 startups selected for the 2025 CancerX Accelerator
Science
Feb 22, 2025, 04:08
Anticancer potential of NO-Donor Oxadiazole in malignant pleural mesothelioma - The Babak Lab